Quick Answer
Polomar Health Services, Inc. reported Diluted EPS of $0.05 per share (loss) for fiscal year 2024.
Polomar Health Services, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.05 | -150.0% |
| 2023 | -$0.02 | — |
| 2022 | $0.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | -100.0% | +0.0% |
| June 30, 2025 | -$0.02 | -100.0% | +0.0% |
| March 31, 2025 | -$0.02 | -100.0% | -100.0% |
| September 30, 2024 | -$0.01 | — | +0.0% |
| June 30, 2024 | -$0.01 | — | +0.0% |
| March 31, 2024 | -$0.01 | -1150.0% | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | +100.0% |
- Polomar Health Services, Inc. showed a decrease of -150.0% in Diluted EPS compared to the prior fiscal year.
- The most recent figure is from Polomar Health Services, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: